Today: August 18, 2018, 9:44 pm
  
Health

Invacare introduce next generation programming to powerchairs

Invacare TDX SP2 Ultra Low Maxx with LiNX
Invacare TDX SP2 Ultra Low Maxx with LiNX
Global brand leader Invacare has revolutionised how powerchairs are programmed – thanks to its LiNX technology.

 

PR-Inside.com: 2017-08-29 11:37:08
Global brand leader Invacare has revolutionised how powerchairs are programmed – thanks to its LiNX technology.

The LiNX control system, found on the renowned Invacare powerchair range, allows professionals to diagnose and update powerchairs more intuitively through its clean and simple interface. Changes can be made to a powerchair via a laptop, PC or iOS device which are connected to the powerchair through a wireless LiNX Access Key.


What makes LiNX programming so innovative is its ‘live’ feature. Changes can be made to the forward, reverse and turn speeds whilst the powerchair is being driven by the user. This increases the driving efficiency and experience and makes set-ups and adjustments easier and quicker for professionals. Feedback is immediate and it ensures the powerchair is configured specifically to the user.

The LiNX system also allows professionals to mix and match the drive, seating and environmental controls in-order-to customise the display to suit the user’s lifestyle. E.g. The profiles can be customised by names such as Home, Outdoor and Work, with functions specific to each one. Profiles can also be set by user input options i.e. head control.

What else does LiNX have to offer?

Invacare is also pleased to present the REM400 remote with its 3.5" interactive screen that requires minimal force to operate. Following extensive customer-insight research, this innovative remote can be configured to a users' physical and cognitive ability, thanks to its extensive functional capabilities. Also available is a REM500, a display only version of the REM400. Both remotes can be used with a wide range of specialist controls.

Specialist controls

To maximise a user's control and independence, the REM400 and REM500 allow a selection of specialist user inputs to be used on Invacare's remarkable powerchairs. They range from head controls, chin controls, Sip 'n' puff systems, joystick options, proximity switches and dual controls, allowing Invacare to provide a control solution for many powerchair users. To help professionals select the best control for a powerchair user, Invacare has put together a useful app with five simple steps to assist with the process. Take a look at the app by visiting www.linx4you.com plus it can downloaded from the Google Play Store and Apple App Store.

Bluetooth technology

The REM400 and REM500 controls have built-in Bluetooth technology to allow users to connect to their PC, Mac and compatible Android devices that have built-in HID functionality.

To find out more about Invacare LiNX, please visit www.invacarelinx.com.

Press Information
Invacare International Sarl
Invacare International Sarl


Benkenstrasse 260


CH-4108 Witterswil


Switzerland

Samantha Hatchett
EMEA Marketing Communications Executive
01656 776236
email
www.invacare.eu.com


# 426 Words
Related Articles
 
More From Health
Drug Abuse Treatment Market to Surpass US$ [..]
(EMAILWIRE.COM, August 06, 2018 ) Global Drug Abuse Treatment Market, by Abuse Type (Alcohol Dependence, Tobacco/Nicotine Addiction, [..]
Sponsors Recommend Novotech for CRO Leadership Award
SYDNEY, Aug 9, 2018 - (ACN Newswire) - Asia-Pacific specialist CRO Novotech has been awarded the "Exceeded Customer Expectations" [..]
Nurse Staffing Agency Website Focuses on Services; [..]
Elkhart, IN; August 1, 2018 – Excellent Nursing Services, Inc. (ENS) has announced the launch of the agency’s website highlighting [..]
Ascletis-developed Ganovo Acquired Extraordinary Achievement
Ganovo Phase III Clinical Study Won the Top Award at the Infectious Disease National Congress of Chinese Medical Association HONG [..]
Primary Sclerosing Cholangitis Market to Reach US$ [..]
(EMAILWIRE.COM, July 30, 2018 ) Global Primary Sclerosing Cholangitis Market, by Drug (BT1023, GS-9674, NGM282, OCA, LUM001, and [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.